S.Korea's MERS-related shares surge on hopes of higher demand for products
10/09/2018 02:07
** Shares of some companies surge on hopes of higher demand
for their products after South Korea confirmed a case of Middle
East Respiratory Syndrome (MERS) urn:newsml:reuters.com:*:nL3N1VU08C
** A local was diagnosed with MERS in South Korea on
Saturday after his business trip from Kuwait
** This is the first time since July 2015 that an outbreak
of the deadly disease has been reported in South Korea
** Shares in Gene One Life Science Inc 011000.KS , engaged
in the research, development and manufacture of DNA vaccines for
MERS, skyrocket as much as 30 pct
** Mask producer Okong Corp 045060.KQ and Welcron Co Ltd
065950.KQ soars as much as 30 pct and 20 pct, respectively
** Pharmaceutical manufacturer Myungmoon Pharm Co Ltd
017180.KS jumps as much as 15.9 pct, while Chasys Co Ltd
033250.KS - its subsidiary Nel Biotech produces disinfectant -
rise up to 13 pct
** Ilyang Pharmaceutical Co Ltd 007570.KS and germicide
Hy-plu supplier Orient Bio Inc 002630.KS gain as much as 3.7
pct and 3.4 pct each
** Broader market .KS11 trades flat, as of 0105 GMT
((joori.roh.thomsonreuters.com@reuters.net))